ABC
IONS icon

Associated Banc-Corp’s Ionis Pharmaceuticals IONS Stock Holding History

Associated Banc-Corp’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-47
Closed -$2K – 1004
2020
Q3 		$2K Hold
47
– – ﹤0.01% 686
2020
Q2 		$3K Hold
47
– – ﹤0.01% 518
2020
Q1 		$2K Buy
+47
New +$2.62K ﹤0.01% 600

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Associated Banc-Corp's IONS Position: Q4 2020 in Review

Associated Banc-Corp sold out of Ionis Pharmaceuticals (IONS) in Q4 2020, closing a stake of 47 shares — an estimated $2K sold.

Associated Banc-Corp first reported a position in IONS in Q1 2020 and held it in 3 quarters. The position peaked at $3K in Q2 2020. 382 funds tracked by Wall St. Rank hold IONS as of Q4 2020.

  • Associated Banc-Corp reported no remaining Ionis Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Associated Banc-Corp sold 47 Ionis Pharmaceuticals shares in Q4 2020, an estimated $2K.
  • Associated Banc-Corp first reported a position in Ionis Pharmaceuticals in Q1 2020 and held it in 3 quarters.
  • Associated Banc-Corp's Ionis Pharmaceuticals position peaked at $3K in Q2 2020.
  • 382 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2020.

Based on Associated Banc-Corp's 13F filing for Q4 2020, filed 11 Feb 2021.